CLINICAL_TRIALS
trial_result
· 2021-04-06
Clinical Trial Update: A Dose-finding and Confirmatory Trial of OPC-6535 in Patients With Active Crohn's Disease [Phase 2, Phase 3]
Summary
Phase 2/3 trial of OPC-6535 in active Crohn's disease completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Crohn's Disease | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2021-04-06